-
Safe DNA Gel Stain: Practical Guidance for Nucleic Acid Visu
2026-05-14
Safe DNA Gel Stain offers a safer, less mutagenic alternative to ethidium bromide for DNA and RNA visualization in agarose or acrylamide gels. It is optimized for blue-light and UV excitation, reducing DNA damage during imaging. However, it is less effective for detecting low molecular weight DNA bands (100–200 bp) and is not recommended for diagnostic use.
-
Sodium Overload Drives NECSO via Mitochondrial Metabolic Dis
2026-05-13
Qiao et al. reveal that sodium influx through TRPM4 channels leads to mitochondrial dysfunction and energy failure, precipitating necrosis by sodium overload (NECSO). This work elucidates a direct mechanistic link between sodium homeostasis and mitochondrial energy metabolism, informing new approaches for studying cell death and disease pathogenesis.
-
Distinguishing Proliferative Arrest and Cell Death in Cancer
2026-05-13
Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drug responses by clearly separating proliferative arrest from cell death in in vitro assays. This approach improves mechanistic understanding and reliability in preclinical drug testing, with practical implications for the design and interpretation of cancer research experiments.
-
RITA (NSC 652287): Protocols and Troubleshooting in Cancer B
2026-05-12
RITA (NSC 652287) delivers potent, selective p53 activation for advanced apoptosis and tumor xenograft assays. This guide details optimized workflows, protocol enhancements, and troubleshooting strategies to maximize research reproducibility and interpretability.
-
Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol on Hepatic Stel
2026-05-12
This study investigates the anti-fibrotic potential of 1-phenyl-2-pentanol (1-PHE), a bioactive compound from Moringa oleifera, using in vitro hepatic stellate cell models. By elucidating the suppression of key fibrogenic pathways and markers, the research offers mechanistic insights relevant to liver fibrosis intervention strategies.
-
Nuclear cGAS Restricts L1 Retrotransposition via TRIM41-Medi
2026-05-11
This study reveals that nuclear cGAS suppresses LINE-1 (L1) retrotransposition in human cells by promoting TRIM41-mediated ubiquitination and degradation of the L1-encoded ORF2p protein. These findings suggest a posttranslational mechanism by which nuclear cGAS maintains genome integrity, with implications for aging and tumorigenesis.
-
Repurposing Vitamins as SARS-CoV-2 3CLpro and Spike Inhibito
2026-05-11
This study systematically identifies natural vitamins with potential to inhibit SARS-CoV-2 by targeting both the main protease (3CLpro) and the spike protein's receptor-binding domain. Utilizing molecular docking and dynamics, the research suggests that safe, affordable vitamins could disrupt viral entry and replication, providing a computational foundation for further antiviral therapeutics research.
-
One-step TUNEL Cy5 Apoptosis Detection Kit: Mechanism & Evid
2026-05-10
The One-step TUNEL Cy5 Apoptosis Detection Kit enables high-sensitivity, fluorescence-based detection of apoptotic DNA fragmentation in tissue sections and cultured cells. It leverages Cy5-conjugated dUTP incorporation at DNA breaks to quantify programmed cell death with robust specificity. This dossier details the kit’s molecular rationale, operational mechanism, validated benchmarks, and workflow integration in apoptosis research.
-
Triacetin (Glyceryl Triacetate): Applied Workflows in Tumor
2026-05-09
Triacetin (glyceryl triacetate) is redefining experimental design in antitumor and metabolic regulation research with robust, quantifiable assay performance. Explore stepwise protocols, troubleshooting, and workflow optimizations that leverage its unique biochemical properties for reproducible results.
-
Improving In Vitro Drug Response Evaluation in Cancer Resear
2026-05-08
Schwartz (2022) challenges conventional in vitro drug evaluation by dissecting the distinct measurements of proliferative arrest and cell death in cancer therapy assessment. The dissertation’s nuanced framework enhances the mechanistic understanding of drug responses, guiding more accurate experimental design and interpretation.
-
Parathyroid hormone (1-34) (human): Precision Tools for Bone
2026-05-08
Harness the robust bioactivity of Parathyroid hormone (1-34) (human) to elevate experimental fidelity in bone metabolism and kidney disease models. This guide translates recent breakthroughs in assembloid modeling and cAMP signaling into actionable protocols and troubleshooting insights.
-
Phosphatase Inhibitor Cocktail 3: Benchmarking Protein Phosp
2026-05-07
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) is a serine/threonine phosphatase inhibitor formulated to preserve protein phosphorylation during sample preparation. This APExBIO solution inhibits PP1, PP2A, and alkaline phosphatases, ensuring accurate downstream phosphoprotein analysis. Its robust formulation supports reproducible results in Western blotting and kinase assays.
-
SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis
2026-05-07
This study uncovers the role of SMYD2 in mediating renal fibrosis and inflammation following cisplatin exposure, showing that pharmacological inhibition of SMYD2 with AZ505 or LLY507 significantly protects against cisplatin-induced chronic kidney disease (CKD) in both in vivo and in vitro models. These findings provide mechanistic insight and suggest new therapeutic strategies to prevent CKD progression in patients receiving cisplatin chemotherapy.
-
CFDA SE Cell Tracer Kit: Practical Guide for Cell Tracking W
2026-05-06
The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit enables reproducible, long-term fluorescent labeling for cell proliferation studies and lineage tracing, addressing the need for stable, covalent, and minimally cytotoxic cell tracking. It is not suitable for applications requiring reversible or short-term labeling.
-
FGF and Shh Signaling Govern Penile Developmental Difference
2026-05-06
This study elucidates the molecular basis for divergent penile development in guinea pigs and mice, specifically implicating differential expression of Shh, Fgf10, and Fgfr2. These findings clarify species-specific morphogenetic mechanisms and suggest broader relevance to human developmental biology.